Results 251 to 260 of about 443,792 (339)
P. Waterhouse, M. Graham, Ming-Bo Wang
semanticscholar +1 more source
When Rare Is Not Small: Amyotrophic Lateral Sclerosis Initiatives and Therapy
In the precision‐medicine era, rare diseases must not be sidelined in translational infrastructure. The Mr. Cai Lei—led “Ice‐Breaking Team” turns an amyotrophic lateral sclerosis patient community into a sustainable ecosystem, realigning philanthropy, data, and research and development to reshape rare‐disease pipelines and guide precision therapies ...
Yang Liu +6 more
wiley +1 more source
Silencing HPV: the rise of RNA therapeutics in cervical cancer. [PDF]
Khorramabadi SM +4 more
europepmc +1 more source
We unveil that CLC orchestrates the dual role of eosinophil recruitment via CCL26 and tissue remodelling via POSTN in allergic rhinitis, identifying it as a potential therapeutic target. ABSTRACT Allergic rhinitis (AR) is a chronic airway inflammation driven by a type 2 immune response, yet the molecular mechanisms underlying its persistence and tissue
Fanyu Yuan +9 more
wiley +1 more source
A nanopore-based HIV-1 reference epitranscriptome. [PDF]
Bosmeny MS +8 more
europepmc +1 more source
Rammohan Devulapally +4 more
semanticscholar +1 more source
Developing antisense oligomer biotics "asobiotics" as precision antibacterials: designs, strategies, and considerations for future success. [PDF]
Moustafa DA +9 more
europepmc +1 more source
ABSTRACT Aedes aegypti, a critical vector for tropical diseases, poses significant challenges for studying its embryogenesis due to difficulties in removing its rigid chorion and achieving effective fixation for in situ hybridization. Here, we present novel methodologies for fixation, dechorionation, DAPI staining, and in situ hybridization, enabling ...
Renata Coutinho‐dos‐Santos +8 more
wiley +1 more source
Comparative TSS-seq analysis among natural variations of <i>Arabidopsis</i> reveals the genetic stability of genic and nongenic promoters. [PDF]
Sugekawa K, Ezeh OS, Yamamoto YY.
europepmc +1 more source

